Regarding papillary thyroid carcinoma (PTC), all of the following statements are true EXCEPT:

## Papillary Thyroid Carcinoma: Distinguishing Features **Key Point:** Papillary thyroid carcinoma is an indolent malignancy with excellent prognosis despite frequent lymph node involvement at presentation. The defining feature is its propensity for lymph node metastasis, NOT distant organ spread. ### Epidemiology & Genetics | Feature | Details | |---------|----------| | Frequency | 80–85% of all thyroid cancers | | Primary genetic alteration | RET/PTC rearrangement (40–70% of cases) | | Other mutations | BRAF V600E (25–40%), TP53, PTEN | | Age of onset | Peak: 40–50 years; can occur in children | **High-Yield:** RET/PTC is a hallmark of PTC and is particularly common in radiation-induced cases (post-Chernobyl, post-atomic bomb exposure). ### Clinical Behavior & Prognosis 1. **Lymph Node Involvement** - Present in 20–50% of patients at diagnosis - Central compartment (level VI) involvement is most common - Lateral neck node metastases occur in 10–15% at presentation - Despite nodal disease, 10-year survival remains >90% 2. **Distant Metastases** - Occur in only 1–5% of patients at initial presentation - Lung is the most common site (80% of distant metastases) - Bone, brain, and liver metastases are rare - Late manifestation (years to decades after primary diagnosis) 3. **Why Prognosis is Excellent** - Slow growth rate - High sensitivity to radioactive iodine (RAI) - Excellent response to thyroid hormone suppression therapy - Most deaths occur in patients >45 years with distant metastases **Clinical Pearl:** A patient with PTC and cervical lymph node metastases should NOT be treated with systemic chemotherapy upfront. The standard approach is total thyroidectomy + central/lateral neck dissection (as indicated) + RAI ablation. Chemotherapy is reserved for RAI-refractory metastatic disease. **Warning:** ~~PTC spreads early to distant organs~~ — this is FALSE. PTC is characterized by early lymph node spread but LATE (or absent) distant metastases. This is the defining difference from anaplastic thyroid carcinoma, which spreads widely and early. ### Why Option 4 is Incorrect Option 4 states that PTC "typically spreads to distant organs early in the disease course, making systemic chemotherapy the primary treatment modality." This is fundamentally wrong: - Distant metastases are LATE events (if they occur at all) - Systemic chemotherapy is NOT the primary treatment - Primary treatment is surgery + RAI, not chemotherapy This option confuses PTC with **anaplastic thyroid carcinoma (ATC)**, which does spread widely and early and requires aggressive multimodal therapy including chemotherapy. [cite:Robbins 10e Ch 24]